Clinical Trial Update: Glutaminergic Agents for Cocaine Abuse - 5 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating glutaminergic agents for cocaine abuse has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cocaine-related Disorders

Drugs mentioned

• Glutaminergic Agents

Snippet

Sponsor: Yale University | Conditions: Cocaine-Related Disorders | Phase 1 | Status: COMPLETED